| Closed |
SWOG-9225 |
Pharmacokinetics of Isotretinoin or All Trans Retinoic Acid: An Ancillary Study to SWOG-9132 |
9/15/1992 |
6/1/1996 |
|
|
Published
|
| Closed |
S0355 |
Phase I Pharmacokinetic Study |
11/1/2003 |
8/15/2006 |
100% |
|
Published
|
| Closed |
S0528 |
Phase I Study of Lapatinib and Everolimus in Advanced Solid Tumors |
9/1/2006 |
8/25/2009 |
100% |
|
Published
|
| Closed |
SWOG-8746 |
Phase I Trial of Dose Intensive Chemotherapy Combined with Granulocyte-Macrophage Colony Stimulating Factor in Advanced Breast Cancer |
9/1/1988 |
9/1/1992 |
67% |
|
Published
|
| Closed |
SWOG-8902 |
Phase I Trial of Doxorubicin plus Carboplatin with GM-CSF in Patients with Advanced, Previously Treated Cancer |
4/15/1990 |
5/1/1992 |
70% |
|
Published
|
| Closed |
SWOG-8922 |
Phase I Trial of Doxorubicin, DTIC and Ifosfamide with Recombinant Granulocyte-Macrophage Colony Stimulating Factor in Advanced Soft Tissue Sarcomas |
9/15/1990 |
9/15/1992 |
28% |
|
Published
|
| Closed |
SWOG-9128 |
Phase I Trial of Doxorubicin, DTIC and Ifosfamide with Recombinant Granulocyte-Macrophage Colony Stimulating Factor/Peripheral Blood Progenitor Cell Infusion in Advanced Soft Tissue Sarcomas |
9/1/1992 |
12/1/1994 |
47% |
|
|
| Closed |
SWOG-8825 |
Phase I Trial of Intravenous Bolus Melphalan With GM-CSF |
12/15/1988 |
12/1/1990 |
87% |
|
Published
|
| Closed |
SWOG-8903 |
Phase I Trial of Promace-CytoBOM with GM-CSF for Treatment of Non-Hodgkin's Lymphoma |
11/15/1989 |
11/1/1993 |
93% |
|
Published
|
| Closed |
S0806 |
Phase I/II DLBCL Vorinostat with R-CHOP |
11/15/2010 |
10/1/2013 |
100% |
|
Published
|
| Closed |
S0720 |
Phase II Adjuvant NSCLC |
11/15/2008 |
5/15/2012 |
100% |
|
Published
|
| Closed |
S0535 |
Phase II ATRA, Arsenic and Mylotarg for Untreated High-Risk APL |
11/15/2007 |
|
100% |
|
|
| Closed |
S0536 |
Phase II Carboplatin, Paclitaxel, Cetuximab and Bevacizumab in Adv. NSCLC |
8/15/2006 |
9/15/2007 |
100% |
|
Published
|
| Closed |
S0709 |
Phase II Carboplatin/Paclitaxel/Erlotinib vs Erlotinib Alone in Advanced NSCLC |
12/1/2008 |
9/15/2014 |
54% |
|
Published
|
| Closed |
S0941 |
Phase II Cholangiocarcinoma with Sorafenib + Erlotinib |
4/15/2010 |
9/15/2011 |
73% |
|
Published
|
| Closed |
S1314 |
Phase II COXEN Trial for Localized Bladder Cancer |
7/9/2014 |
12/1/2017 |
100% |
|
|
| Closed |
SWOG-9350 |
Phase II Disseminated Malignant Melanoma |
8/1/1994 |
11/13/1996 |
39% |
|
Published
|
| Closed |
S0333 |
Phase II Double Induction for Newly Diagnosed Non-L3 ALL |
4/15/2005 |
|
100% |
|
|
| Closed |
S1001 |
Phase II Early Stage DLBCL |
7/18/2011 |
6/1/2016 |
100% |
|
|
| Closed |
S0125 |
Phase II Elderly AML in First Complete Remission |
4/1/2003 |
6/1/2005 |
10% |
|
|
